Navigation Links
Roche Announces Back-to-Basics Approach to Diabetes Care - Simpler is Better

People with diabetes can improve their general health and self-care management by using simple tools to uncover links between lifestyle and blood glucose levels.

INDIANAPOLIS, May 28 /PRNewswire/ -- Roche, the maker of ACCU-CHEK(R) blood glucose monitoring systems and insulin pumps, announced today the availability of two new tools that can help patients pinpoint food and lifestyle choices that have the biggest impact on their blood glucose levels, giving them greater control in their everyday battles against diabetes.

As the world leader in diabetes diagnostics, Roche is rolling out the ACCU-CHEK Testing in Pairs and ACCU-CHEK 360-degree View tools as a way to help adults, children and teens manage their diabetes more easily and more effectively. The initiative is part of Roche's Behavior Change through Patient Engagement (sm) program.

"Diabetes is a 24/7 disease that doesn't give patients a day off," said Dan Kane, vice president of marketing for Roche Diabetes Care North America. "It's relentless, and we understand how difficult it can be to stay motivated, especially when it's not clear what affects blood sugar levels or why the numbers on a patient's meter rise and fall like they do. These simple tools bring clarity to the meaning of those numbers and, more importantly, help patients better understand what influences their results -- and what they can do to improve them."

The ACCU-CHEK Testing in Pairs tool is a simple paper-based way to track blood sugar responses to everyday situations like stress, exercise and eating out. By comparing before-and-after readings around single events for seven days, patients can zero in on one thing that makes a difference for them, instead of trying to change everything at once.

The ACCU-CHEK 360-degree View tool is a paper chart that offers a seven-point profile of blood glucose control. In just three days, it gives a more complete picture of the effectiveness of prescriptions, as well as how food portions affect blood glucose and energy levels. Discovering these patterns may help patients and their healthcare providers quickly see if adjustments are needed.

"By tracking results over time, patients see how balanced meals and medication--even changes brought about by these simple tools--alter blood sugar levels," Kane said. "The initiative not only helps people understand their numbers better, it allows them to take a greater role in developing effective plans with their healthcare providers for more successful outcomes."

For a free download and more information, please visit and

About Roche Diabetes Care

Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients' condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management--from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems.

For more information, please visit

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients.

In 2008, Roche had over 80,000 employees worldwide and invested almost 9 billion Swiss francs in R & D. The Group posted sales of 45.6 billion Swiss francs. Genentech (United States) is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical (Japan). For more information, visit

All trademarks used or mentioned in this release are protected by law.

    For further information, please contact:
    Julie Vincent
    Public Relations Manager
    ACCU-CHEK Brand

SOURCE Roche Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
2. Roche Extends Tender Offer for Ventana
3. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
4. Roche Real-Time HIV Test is Faster and Less Labor-Intensive Than Competitors
5. Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development
6. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
7. Med Ad News Honors Roche as Company of the Year
8. MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City
9. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
10. Phase I Results Announced for R1507 From Genmabs Collaboration With Roche
11. Kosan to Reacquire Epothilone Program From Roche
Post Your Comments:
(Date:11/30/2015)... (PRWEB) , ... November 30, ... ... Company, today announced tighter software integration with MarkLogic, the Enterprise NoSQL database ... maximize information to drive change. , Smartlogic’s Content Intelligence capabilities provide a ...
(Date:11/27/2015)... /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ), a ... closed the sale of its global contrast media and ... in a transaction valued at approximately $270 million. The ... total of approximately 1,000 employees spread across the globe, ... area. This entire workforce and the manufacturing ...
(Date:11/26/2015)... November 26, 2015 ... Accutest Research Laboratories, a leading ... Organization (CRO), has formed a strategic ... - Temple Health for joint work ... (Photo: ) , --> ...
(Date:11/25/2015)... ANNAPOLIS, Md. , Nov. 25, 2015  PharmAthene, ... of Directors has adopted a stockholder rights plan (Rights ... its net operating loss carryforwards (NOLs) under Section 382 ... --> --> PharmAthene,s use of its ... an "ownership change" as defined in Section 382 of ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has entered ... MIT and Harvard for use of its ArxLab ... management tools. The partnership will support the institute,s ... and chemical research information internally and with external ... used for managing the Institute,s electronic laboratory notebook, ...
(Date:11/10/2015)... 2015  In this report, the biomarkers ... product, type, application, disease indication, and geography. ... are consumables, services, software. The type segments ... efficacy biomarkers, and validation biomarkers. The applications ... development, drug discovery and development, personalized medicine, ...
(Date:11/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), the leading ... into the automotive market with a comprehensive and dedicated ... consumer electronics human interface innovation. Synaptics, industry-leading touch controllers, ... automotive industry and will be implemented in numerous locations ... , Japan , and ...
Breaking Biology News(10 mins):